A new drug made in Ireland could cut the risk of heart failure by 25%.
The findings were outlined by the European Society of Cardiology Congress in Sweden and will be published in the Lancet medical Journal.
The study involved more than 6,500 patients from 37 countries.
It found that the drug ‘ivabradine’ which is manufactured in Co. Wicklow reduced death and hospitalisation due to heart failure by 26% in patients with moderate to severe heart failure.
